Evidence map›Paper›PMID 42523822›Full record

ArticleFrontiers in aging neuroscience2026

Multivariate associations between systemic inflammation, metabolic dysregulation, and cognitive performance in project FRONTIER.

Chathurika S Dhanasekara, Chanaka N Kahathuduwa, Volker Neugebauer

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chathurika S DhanasekaraDepartment of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Chanaka N KahathuduwaCenter for Translational Neuroscience and Therapeutics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Volker NeugebauerDepartment of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.

Funding

PAIN, NOCICEPTION, AND THE AMYGDALAR01NS038261 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Volker Neugebauer, Igor Ponomarev · 1999 to 2026
$8.7M
NINDS NIH HHS R01 NS038261
6 · The paper itself

Abstract

Background: Cognitive aging is heterogeneous, and growing evidence implicates chronic low-grade inflammation and metabolic dysregulation in neuropathology and cognitive decline. This study examined the multivariate relationship between inflammatory-metabolic biomarkers and neuropsychological performance in a large, community-based cohort of adults from rural West Texas enrolled in Project FRONTIER. Methods: Participants aged ≥ 40 years who completed a study visit in the Project FRONTIER study were included ( Results: CCA revealed a significant multivariate association between inflammatory-metabolic biomarkers and cognitive performance. The first canonical correlation was 0.242 (95% CI: 0.171-0.310), accounting for 5.8% of the shared variance between the biological and cognitive domains. This association was statistically significant based on both Wilks' lambda ( Conclusion: Systemic inflammation and metabolic dysregulation were associated with poorer cognitive performance, particularly executive dysfunction, in this rural aging cohort. These findings, while modest in effect size, support the importance of cardiometabolic health in cognitive aging, motivating future longitudinal and mechanistic studies.

Indexed as

biomarkerscognitive functioningexecutive functionsinflammationmetabolic marker

Identifiers

PMID42523822
PMCPMC13407628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.